Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported ...

AstraZeneca PLC closed 23.78% short of its 52-week high of £133.88, which the company achieved on September 3rd.

Summit Therapeutics is considering an up to $15 billion partnership with AstraZeneca, Bloomberg News reported on Thursday, ...